Furthermore, intrasplenic injection of CAND1 knockdown Hep3B cells led to fewer liver tumour nodules than injection of shNC cells, while tail vein injection of CAND1 knockdown Hep3B cells caused significantly fewer tumour nodules in the lung than injection of shNC cells (Figure 2L–P). The gene discussed is CAND1; the disease is neoplasm.